Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma

Canadian Journal of Ophthalmology

Volumn 44, Issue 1, 2009, Pages 106-107

  Vásquez, Luz Maria ^a   Somani, Sohel ^a   Altomare, Filiberto ^a,b   Simpson, E Rand ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; IODINE 125;

ADULT; BRACHYTHERAPY; CANCER PATIENT; CASE REPORT; CHOROID MELANOMA; DRUG MECHANISM; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; LETTER; NEOVASCULAR GLAUCOMA; RETINA DETACHMENT;

EID: 59849119842     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I08-171     Document Type: Letter

References (8)

1. Gündüz K, Shields CL, Shields JA. Cater J, Freire JE, Brady LW. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 1999;127:579-89.
2. Shields CL, Naseripour M, Cater J, et al. Radiotherapy for large posterior uveal melanomas (> or = 8-mm thick) in 354 consecutive patients. Ophthalmology 2002;109:1838-49.
3. Detorakis ET, Engstrom RE Jr, Wallace R, Straatsma BR. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma. Ophthalmology 2005;112:505-10.
4. Mills M, Harbour JW. Lipid exudation following plaque radiotherapy for posterior uveal melanoma. Am J Ophthalmol 2006;141:594-5.
5. Mason JO 3rd, Albert MA Jr, Mays A, Vail R. Regression of neovascular iris vessels by intravitreal injection if bevacizumab. Retina 2006;26:839-41.
6. Grisanti S, Biester S, Peters S, Tatar O, Ziemssen K, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group. Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol 2006;142:158-60.
7. Boyd SR, Zachary I, Chakravarthy U, et al. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol 2002;120:1644-50.
8. Missotten GS, Notting IC, Schlingemann RO, et al. Vascular endothelial growth factor a in eyes with uveal melanoma. Arch Ophthalmol 2006;124:1428-34.